Leukemia, Lymphoblastic, Acute, Lymphoma research hub

Immunotherapy for High Risk/Relapsed CD19+ Acute Lymphoblastic Leukaemia, B-cell Non-Hodgkin's Lymphoma (B-NHL) and Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) Using CAR T-cells to Target CD19

This study looks at a new type of treatment called CAR T-cell therapy for certain blood cancers that have come back or are high-risk. It uses a patient's own specially modified cells to fight cancer. The study aims to see how safe and effective this treatment is.